I am thinking of it this way. Pre-CV, we would have expected the NGIO S-1 to directly follow the approval of the Form 10. That hasn’t happened... so there must be some sort of news coming that would cause a Joe to delay that S-1, believing there is improvement to be made in the deal... of course, I could be wrong.
Also, smarter minds than mine have questioned the data from the OTCShortReport... so we might not want to take that at face value.
(2)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links